Literature DB >> 9882289

Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.

U Schubert1, S Bour, R L Willey, K Strebel.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Vpu and Env proteins are expressed from a bicistronic mRNA. To address the biological significance of the coordinated expression of vpu and env, we compared the relative effects on particle release of HIV-1 isolates containing an intact vpu gene or carrying point mutations in its initiation codon or internal deletions, respectively. We found that the primary AD8 isolate, which is unable to express vpu due to a mutation in its translation initiation codon, was able to replicate in primary macrophages and peripheral blood mononuclear cells with efficiency similar to that of an isogenic variant expressing Vpu. Interestingly, AD8 lacking a vpu initiation codon produced higher levels of Env protein than its Vpu-expressing isogenic variant. In contrast, disabling Vpu without removing the vpu initiation codon did not alter Env expression but significantly reduced virus production. AD8 Env when provided in trans was capable of enhancing release not only of AD8 particles but also of viruses of the T-cell-tropic NL4-3 isolate. We conclude that AD8 Env encodes a Vpu-like activity similar to that previously reported for HIV-2 Env proteins and is thus able to augment virus secretion. When expressed at elevated levels, i.e., following mutation of the vpu initiation codon, AD8 Env was able to compensate for the lack of Vpu and thereby ensure efficient virus release. Thus, the ability to regulate virus release is redundant in AD8 and can be controlled by either Vpu or Env. Since Vpu controls several independent functions, including CD4 degradation, our results suggest that some HIV-1 isolates may have evolved a mechanism to regulate Vpu activity without compromising their ability to efficiently replicate in the host cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882289      PMCID: PMC103908     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.

Authors:  B Crise; L Buonocore; J K Rose
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  The lipophilic muramyl peptide MTP-PE is a potent inhibitor of HIV replication in macrophages.

Authors:  J K Lazdins; K Woods-Cook; M Walker; E Alteri
Journal:  AIDS Res Hum Retroviruses       Date:  1990-10       Impact factor: 2.205

3.  The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release.

Authors:  T Klimkait; K Strebel; M D Hoggan; M A Martin; J M Orenstein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems.

Authors:  W Wilson; M Braddock; S E Adams; P D Rathjen; S M Kingsman; A J Kingsman
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

5.  Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.

Authors:  M A Jabbar; D P Nayak
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.

Authors:  S Schwartz; B K Felber; E M Fenyö; G N Pavlakis
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Functional role of human immunodeficiency virus type 1 vpu.

Authors:  E F Terwilliger; E A Cohen; Y C Lu; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

8.  Replication of HIV-1 in primary monocyte cultures.

Authors:  B J Potts; W Maury; M A Martin
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

9.  Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  P L Earl; R W Doms; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  38 in total

1.  An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus.

Authors:  S Gummuluru; C M Kinsey; M Emerman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.

Authors:  Nolwenn Jouvenet; Stuart J D Neil; Maria Zhadina; Trinity Zang; Zerina Kratovac; Youngnam Lee; Matthew McNatt; Theodora Hatziioannou; Paul D Bieniasz
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

Review 3.  HIV-1 Vpu - an ion channel in search of a job.

Authors:  Klaus Strebel
Journal:  Biochim Biophys Acta       Date:  2013-07-03

4.  Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.

Authors:  Maxime Veillette; Anik Désormeaux; Halima Medjahed; Nour-Elhouda Gharsallah; Mathieu Coutu; Joshua Baalwa; Yongjun Guan; George Lewis; Guido Ferrari; Beatrice H Hahn; Barton F Haynes; James E Robinson; Daniel E Kaufmann; Mattia Bonsignori; Joseph Sodroski; Andrés Finzi
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Selection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 protein.

Authors:  T E Hamm; D Rekosh; M L Hammarskjöld
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.

Authors:  Kenta Matsuda; Chia-Yen Chen; Sonya Whitted; Elena Chertova; David J Roser; Fan Wu; Ronald J Plishka; Ilnour Ourmanov; Alicia Buckler-White; Jeffrey D Lifson; Klaus Strebel; Vanessa M Hirsch
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

7.  The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter].

Authors:  S Wyss; C Berlioz-Torrent; M Boge; G Blot; S Höning; R Benarous; M Thali
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.

Authors:  Paolo Abada; Beth Noble; Paula M Cannon
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 9.  Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.

Authors:  Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2009-01-24       Impact factor: 4.602

Review 10.  Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection.

Authors:  Samuele E Burastero; Mariangela Figini; Barbara Frigerio; Paolo Lusso; Luca Mollica; Lucia Lopalco
Journal:  J Transl Med       Date:  2009-11-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.